Docosahexaenoic acid inhibits U46619- and prostaglandin F

15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid Animals Basilar Artery Docosahexaenoic Acids Humans Rats Receptors, Thromboxane A2, Prostaglandin H2
Docosahexaenoic acid (DHA) Pig basilar artery Pig coronary artery Prostaglandin F(2α) Prostanoid TP receptor U46619

Journal

European journal of pharmacology
ISSN: 1879-0712
Titre abrégé: Eur J Pharmacol
Pays: Netherlands
ID NLM: 1254354

Informations de publication

Date de publication:
05 Oct 2021
Historique:
received: 20 04 2021
revised: 06 07 2021
accepted: 21 07 2021
pubmed: 31 7 2021
medline: 8 1 2022
entrez: 30 7 2021
Statut: ppublish

Résumé

Docosahexaenoic acid (DHA, an n-3 polyunsaturated fatty acid) inhibits U46619 (a TP receptor agonist)- and prostaglandin F

Identifiants

DOI: 10.1016/j.ejphar.2021.174371 PMID: 34329614
pubmed: 34329614
pii: S0014-2999(21)00524-0
doi: 10.1016/j.ejphar.2021.174371
pii:
doi:

Substances chimiques

Receptors, Thromboxane A2, Prostaglandin H2 0
Docosahexaenoic Acids 25167-62-8
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid 76898-47-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

174371

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Auteurs

Kento Yoshioka (K)

Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi-City, Chiba, 274-8510, Japan.

Keisuke Obara (K)

Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi-City, Chiba, 274-8510, Japan. Electronic address: keisuke.obara@phar.toho-u.ac.jp.

Shunya Oikawa (S)

Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi-City, Chiba, 274-8510, Japan.

Kohei Uemura (K)

Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi-City, Chiba, 274-8510, Japan.

Akina Yamaguchi (A)

Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi-City, Chiba, 274-8510, Japan.

Kazuki Fujisawa (K)

Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi-City, Chiba, 274-8510, Japan.

Hitomi Hanazawa (H)

Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi-City, Chiba, 274-8510, Japan.

Miki Fujiwara (M)

Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi-City, Chiba, 274-8510, Japan.

Taison Endoh (T)

Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi-City, Chiba, 274-8510, Japan.

Taichi Suzuki (T)

Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi-City, Chiba, 274-8510, Japan.

Montserrat De Dios Regadera (M)

Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi-City, Chiba, 274-8510, Japan.

Daichi Ito (D)

Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi-City, Chiba, 274-8510, Japan.

Guanghan Ou (G)

Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi-City, Chiba, 274-8510, Japan.

Keyue Xu (K)

Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi-City, Chiba, 274-8510, Japan.

Yoshio Tanaka (Y)

Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi-City, Chiba, 274-8510, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Facteurs biologiques › Médiateurs de l'inflammation › Prostaglandines synthétiques › Prostaglandines endoperoxydes synthétiques › Acide 15-hydroxy-11alpha,9alpha-(époxyméthano)prosta-5,13-diénoïque › Docosahexaenoic acid inhibits U46619- and...
questionsmedicales.fr › Eucaryotes › Animaux › Docosahexaenoic acid inhibits U46619- and...
questionsmedicales.fr › Système cardiovasculaire › Vaisseaux sanguins › Artères › Artère basilaire › Docosahexaenoic acid inhibits U46619- and...
questionsmedicales.fr › Lipides › Huiles › Huiles de poisson › Acides gras omega-3 › Acide docosahexaénoïque › Docosahexaenoic acid inhibits U46619- and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Docosahexaenoic acid inhibits U46619- and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Rats › Docosahexaenoic acid inhibits U46619- and...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs couplés aux protéines G › Récepteurs aux éicosanoïdes › Récepteur thromboxane › Récepteurs du thromboxane 2 et prostaglandine H2 › Docosahexaenoic acid inhibits U46619- and...